Companies/HK/1877

SHANGHAI JUNSHI BIOSCIENCES CO., LTD. · 君实生物

Last · HKSEHK$16.32-0.08 (-0.49%)close · yahoo · 7h ago
Vol 1.11M ≈ 18.16M
Market capHK$16.7B260.3M sh
P/E · TTM-40.7fwd 81.8 · eps -0.45 · loss
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
HK$15.25HK$30.80
Volume200session

Issuer

Legal nameSHANGHAI JUNSHI BIOSCIENCES CO., LTD. · 君实生物
HQHong Kong (HK)
ListingHK 1877
ISINCNE100003FF7
LEI300300L36FLCKN0WXW06
SectorHealthcare
IndustryPharmaceuticals
CurrencyCNY
Entity registrycninfo:GFBJ0833330
Org IDGFBJ0833330
Websitewww.junshipharma.com
Employees2,903
AddressShanghai Junshi Biosciences Co., Ltd. 13th Floor, Building 2 201203, Shanghai
Headline financial metrics
Revenue¥1.7B
Operating income¥70.9M
Net income¥25.5M
Operating margin4.2%
Net margin1.5%
Return on equity0.0%
Period2026
Loading chart…

Upcoming earnings

1 event
9:10 AM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
0
View upcoming earnings →

Press & signals

1 recent
  • GlobeNewswire

    Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate Updates

Documents

FormReporting forFiledFlags
DISCLOSURE君实生物H股公告
—2026-10-080
8-K君实生物关于向2025年A股股票期权激励计划激励对象授予预留股票期权的公告
2026-09-232026-09-240
DISCLOSURE根据2025年A股股票期权激励计划预留授予的A股股票期权、首次授予A股股票期权第一个行权期行使条件达成以及若干A股股票期权的注销
2026-09-232026-09-230
上海君实生物医药科技股份有限公司第四届董事会第二十三次会议决议公告海外监管公告 - 上海君实生物医药科技股份有限公司第四届董事会第二十三次会议决议公告
2026-09-232026-09-230
上海君实生物医药科技股份有限公司关于召开2026年半年度业绩说明会的公告海外监管公告 - 上海君实生物医药科技股份有限公司关于召开2026年半年度业绩说明会的公告
2026-09-042026-09-040
Showing 5 of 85 filings